Similar companies
Are Members of Congress Buying or Selling Globus Medical?
No members of Congress have reported trading Globus Medical (GMED) stock in the past 90 days. The history below covers the past two years.
Congressional trading is one of the alternative data signals AltIndex tracks as part of the GMED AI Score. For corporate insider activity, see GMED insider transactions. To browse trades across every ticker, visit the Congress Trading tracker.
GMED Congressional Trade History
| Member of Congress | Trade Date | Type | Estimated Size |
|---|---|---|---|
| Lisa McClain | Jun 17, 2025 | Buy | $1K – $15K |
Frequently Asked Questions: Globus Medical Congress Trading
No members of Congress have reported buying or selling GMED stock in the past 90 days. Congressional trades are disclosed under the STOCK Act — view the full history on this page.
Some research has found that congressional stock trades have at times outperformed the market, possibly due to informational advantages. AltIndex tracks these trades as one of 25+ signals in the AI Score. See the full Congress Trading tracker for all recent trades.
Lisa McClain bought Globus Medical (GMED) stock most recently, on June 17, 2025.
The estimated net value of congressional trades in Globus Medical over the past 2 years is positive, at $8,000, meaning members of Congress have on balance bought more than they have sold.
Members of Congress can have early visibility into legislation, regulation, and government contracts that may affect a company. Tracking their disclosed trades — alongside other signals — can offer additional context for investment decisions.
